Consensus EPS · Q2 2026
$0.54
Consensus revenue · Q2 2026
$7.2B
Analysts
9
Expected report
Aug 6, 2026
What to watch
- Analyst ratings: Upgrades trending
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $7B | $7.2B | $7.3B |
| EPS | $0.53 | $0.54 | $0.55 |
| EBITDA | $1.8B | $1.9B | $1.9B |
| EBIT | $1.5B | $1.5B | $1.5B |
| Net income | $706.2M | $732.8M | $812.8M |
- Revenue$7.2B
- EPS$0.54
- EBITDA$1.9B
- EBIT$1.5B
- Net income$732.8M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $4B | $3.8B | +3.7% | $0.39 | $0.37 | +4.7% |
- Q1 2026+3.7%+4.7%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Keurig Dr Pepper (KDP) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 3 analysts.
- Low
- $28.00
- Consensus
- $34.40
- Median
- $37.00
- High
- $39.00
- Current
- $30.20
- Upside
- +13.9%
Upside calculated vs most recent trading price of $30.20.
Analyst ratings
Consensus: Buy — based on 28 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2026 | UBS | maintain | Buy | Buy |
| Jul 14, 2026 | Citigroup | maintain | Buy | Buy |
| Jun 25, 2026 | Barclays | upgrade | Equal Weight | Overweight |
| Apr 27, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Apr 24, 2026 | UBS | maintain | Buy | Buy |
| Apr 24, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Apr 24, 2026 | Evercore ISI Group | maintain | In Line | In Line |
| Apr 22, 2026 | BNP Paribas | upgrade | Underperform | Neutral |
| Apr 16, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Apr 15, 2026 | Citigroup | maintain | Buy | Buy |
- Jul 16, 2026UBSBuy
- Jul 14, 2026CitigroupBuy
- Jun 25, 2026BarclaysOverweight
- Apr 27, 2026BarclaysEqual Weight
- Apr 24, 2026UBSBuy
- Apr 24, 2026JP MorganOverweight
- Apr 24, 2026Evercore ISI GroupIn Line
- Apr 22, 2026BNP ParibasNeutral
- Apr 16, 2026JP MorganOverweight
- Apr 15, 2026CitigroupBuy
Frequently asked questions
Keurig Dr Pepper (KDP) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.